Campylobacter and Salmonella cases stable in EU

Written by Embio Diagnostics

February 25, 2021

The number of reported human cases of illness caused by Campylobacter and Salmonella bacteria across Europe appears to be stabilising over the past five years, according to the latest report on zoonotic diseases by the European Food Safety Authority (EFSA) and the European Centre for Disease Prevention and Control (ECDC).

Campylobacteriosis, which has been the most reported gastrointestinal disease in EU since 2005, affected more than 220,000 people in 2019. Salmonellosis was the second most reported zoonotic disease in the EU, affecting about 88,000 people.

Of the 66,113 samples of ready-to-eat foods – foods that do not need to be cooked prior consumption – 0.3% tested positive for Salmonella. Of the 191,181 non ready-to-eat samples, 1.5% were positive. Eighteen of the 26 Member States reporting on Salmonella control programmes in poultry populations met all the reduction targets, compared to 14 in 2018.

The next most reported diseases were Shiga toxin-producing Escherichia coli (STEC) infections, yersiniosis and listeriosis. The trend of confirmed human cases of listeriosis was stable in 2015-2019, after a long period of increase. There were 2,621 cases reported in 2019, mainly affecting people over 64 years old. It was the most severe zoonotic disease, with high rates of hospitalisation (92%) and fatality (17.6%).

The report also monitors the cause of foodborne disease outbreaks in the EU, events during which at least two people contract the same illness from the same contaminated food. Salmonella remained the most frequently detected agent and caused 926 outbreaks, but the number of outbreaks due to S. Enteritidis decreased. The most common sources of salmonellosis outbreaks were eggs and egg products. Noroviruses in fish and fishery products caused the highest number (145) of outbreaks that have “strong evidence” implicating a food source.

A total of 5,175 foodborne outbreaks were reported in 2019, a decrease of 12.3% compared to 2018.

The report also includes data on Mycobacterium bovis/caprae, Brucella, Yersinia, Trichinella, Echinococcus, Toxoplasma gondii, rabies, Q fever, West Nile virus and tularaemia.

https://www.efsa.europa.eu/en/news/campylobacter-and-salmonella-cases-stable-eu

You May Also Like…

About Us.

EMBIO Diagnostics (EMBIO) designs and develops custom based hardware solutions and consults as an expert in the biotechnology field at a global scale.

Follow our developments:

 

Contact us

Get In Touch

Cyprus

(+357) 22515175
info@embiodiagnostics.eu
M-F: 9am-6pm

Athalassas Avenue 8B,2018, NIcosia

USA

(+001) 973 876 1792

sales@embiodiagnostics.eu